Polarized neurites (axons and dendrites) form the functional circuitry of the nervous system. Secreted guidance cues often control the polarity of neuron migration and neurite outgrowth by regulating ion channels. Here, we show that secreted semaphorin 3A (Sema3A) induces the neurite identity of Xenopus spinal commissural interneurons (x SCINs) by activating Ca V 2.3 channels (Ca V 2.3). Sema3A treatment converted the identity of axons of cultured x SCINs to that of dendrites by recruiting functional Ca V 2.3. Inhibition of Sema3A signalling prevented both the expression of Ca V 2.3 and acquisition of the dendrite identity, and inhibition of Ca V 2.3 function resulted in multiple axon-like neurites of x SCINs in the spinal cord. Furthermore, Sema3A-triggered cGMP production and PKG activity induced, respectively, the expression of functional Ca V 2.3 and the dendrite identity. These results reveal a mechanism by which a guidance cue controls the identity of neurites during nervous system development.
Developing neurons become polarized to form axons and dendrites [1] [2] [3] . How immature neurites of developing neurons acquire identities as axons/dendrites remains elusive. It was recently revealed that extracellular signalling molecules induce the axon identity 4, 5 , but it remains unknown whether they also induce the dendrite identity, and if so, how.
In vivo, acquisition of an identity as either an axon or dendrite occurs at different phases of neuronal polarization; a developing neuron initially acquires an axon extending from the soma and subsequently either a single dendrite as in C. elegans 6 or multiple dendrites as in most vertebrates 1, 2 . Dendrites develop from undifferentiated neurites that emanate either directly from the soma, as in cerebellar granule cells 2 , or from the tip of the leading process, as in cortical pyramidal neurons 2 , or from the axonal initial segment, as in Xenopus spinal commissural interneurons (xSCINs; refs 7,8) . For example, after xSCIN axons cross the midline of the floor plate and bifurcate into ascending and descending axon branches on the opposite side of the lateral fascicle, multiple neurites extend toward the pial surface and ventrally into the marginal zone from the axonal initial segment at tailbud stages 32-34 (ref. 7) . How these undifferentiated neurites acquire their dendrite identity is unknown. It is likely that specific, spatiotemporally regulated extracellular signals activate intracellular signalling pathways to specify the dendrite identity.
Extracellular guidance factors can induce either attraction or repulsion of growth cones 9, 10 , or reverse the direction of neuron migration 11 by causing changes in intracellular Ca 2+ levels, suggesting that external factors trigger early signalling events that initiate cellular processes by regulating ion channels. Sema3A, a secreted molecule, functions in several neuronal processes, including the orientation and maturation of dendrites [12] [13] [14] [15] . Sema3A binds to its receptor, neuropilin-1 (Npn-1), in Xenopus spinal neuron growth cones and triggers local production of cyclic guanosine monophosphate (cGMP) by soluble guanylate cyclase (sGC; ref. 16 ). Depending on their intracellular cGMP level ([cGMP] i ), growth cones are either repelled from or attracted toward Sema3A; low [cGMP] i induces repulsion 16 through the activation of cyclic-nucleotide-gated cation channels 17 and high
[cGMP] i induces attraction 16, 18 through the activity of an unidentified channels or channels. High-level Sema3A expressed at the pial surface of the neocortex contributes to the attraction of dendrites 12 . Interestingly, a relatively high level of Sema3A is expressed in the marginal zone of the Xenopus spinal cord at tailbud stages 30-32 (ref. 17) , immediately before the emergence of putative dendrites from the axonal initial segment of xSCINs (ref. 7) . Here, we report that, both in vitro and in vivo, Sema3A induces the dendrite identity and simultaneously suppresses the axon identity of xSCINs by regulating cGMP signalling and the expression of functional Ca V 2.3 channels (Ca V 2.3). that emerged from the soma. Neurons were treated with Sema3A and SNP-1 (20 nM, +SNP-1; e), with netrin-1 (5 µg ml −1 ; e), with Sema3A and SNX-482 (j), with Sema3A and nimodipine (20 µM, +nimo; j), or with Sema3A and ω-conotoxin GVIA (1 µM, +CgTX; j). The dark-grey bar represents tau-1-positive growth cones cultured on a laminin substrate for 3 h (e). Data are means ± s.e.m. (n), number of cultures (about 210-450 neurons with neurites about 100-250 µm long) examined. Significant differences from the control (e) and Sema3A (j) are indicated ( * * P < 0.01), respectively.
RESULTS

Sema3A converts the identity of axons to dendrites in vitro
Unlike cultured hippocampal neurons 19 , cultured xSCINs from stage 26 embryos 16, 17 have neurites that are predominantly mono- (Fig. 1a-d ,f-i) or bipolar ( Supplementary Fig. S1a,b) , without substantial branches ( Supplementary Fig. S2 ) or other distinguishing features of axons and dendrites. When cultured on poly-l-lysine for 16 h, most neurons were unpolarized, largely immunonegative for both axonal markers tau-1 and GAP-43 and dendritic marker MAP2 ( Supplementary Fig. S3a,b) . When cultured on laminin for either 3 or 6 h, most of these unpolarized neurites became tau-1-positive axons 20 ( Fig. 1a,e) . However, when these neurites were treated with Sema3A for 3 h, the tau-1 immunoreactivity was markedly decreased (Fig. 1b,e) while MAP2 immunoreactivity was significantly increased (Fig. 1d,e) . Both changes were prevented by bath-applied SNP-1, the soluble Npn-1 ectodomain peptide that sequesters Sema3A ( Fig. 1e; ref. 21 ), indicating the specificity of Sema3A. Sema3A promotes the outgrowth and branching of dendrites of cortical pyramidal neurons 13, 14 and axotomy causes conversion of preformed axons of cultured hippocampal neurons to dendrites 22, 23 . We did not observe significant morphological changes in the length or branching of xSCIN neurites after Sema3A treatment ( Supplementary Fig. S2 ). Netrin-1, another secreted factor that effects axon initiation in Caenorhabditis elegans 4 , had no significant effect on the expression of tau-1 or MAP2 immunoreactivity (Fig. 1e) . We also monitored functional α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors, which are present predominantly in dendrites 22, 24 , by measuring holding-current shifts induced by a gradient of AMPA. Significant AMPA currents were detected in almost all growth cones treated with Sema3A, but only in less than 30% of control growth cones ( Supplementary Fig. S4 ). Thus, Sema3A probably initiates conversion of the identity of axons to dendrites before morphological changes occur.
To determine whether conversion of the neurite identity initiates within the growth cone, we applied a gradient of Sema3A to one growth cone of bipolar neurons ( Supplementary Fig. S1a ). The majority of those neurites that faced the source of the Sema3A became MAP2-positive dendrites, but those that faced away from the source remained MAP2 negative ( Supplementary Fig. S1b,c) . Downstream signalling events induced by Sema3A in the growth cone, therefore, are probably sufficient to initiate conversion of the neurite identity.
Sema3A-induced conversion of neurite identity requires Ca V 2.3
Guidance cues induce growth-cone membrane potential shifts: attractants cause depolarization and repellents cause hyperpolarization 16 . A relatively high concentration of Sema3A induced growth-cone depolarization of about 15 mV from the resting potential of control growth cones, but not in growth cones pretreated with SNP-1 (data not shown) or that overexpressed a mutant Npn-1 (NP-1 (0111); refs 16,17; Supplementary Fig. S5b,c) . This 15 mV depolarization should be sufficient to cause Ca 2+ entry through voltage-dependent Ca 2+ channels. Functional L-, N-, R (Ca V 2.3)-and T-type Ca 2+ channels, but not P/Q types 25 , have been detected in cultured embryonic Xenopus spinal neurons [26] [27] [28] [29] . We used a computed biophysical growth-cone model 17 to identify those Ca 2+ channels that would be active preferentially during Sema3A-induced membrane depolarization. This model predicted that mainly Ca V 2.3 would conduct Ca 2+ , that T types would undergo voltage-dependent inactivation and that activation of L/N types would require further depolarization ( Supplementary Fig. S5d ). We then examined the effect of Ca V 2.3 on the ability of Sema3A to induce the dendrite identity. A specific Ca V 2.3 inhibitor, SNX-482, in the bath indeed prevented conversion of the tau-1-positive axons to the MAP2-positive dendrites (Fig. 1h-j) , but inhibitors of neither L types (nimodipine) nor N types (ω-conotoxin GVIA) prevented the conversion (Fig. 1j) . Thus, in vitro, Sema3A-induced conversion of xSCIN axons to dendrites depends on Ca V 2.3 activity.
Sema3A recruits functional Ca V 2.3
To determine whether Sema3A causes activation of Ca V 2.3, we measured Ca 2+ currents in the growth cone 17, 29 in the presence of a gradient of Sema3A. High-voltage-activated (HVA) Ca 2+ currents were measured in the presence of bath-applied pimozide, a T-type channel blocker. We then isolated N-and R (Ca V 2.3)-type currents by blocking residual T-and L-type currents with nimodipine 29 . Sema3A caused an increase in total N-and R (Ca V 2.3)-type currents (Fig. 2b,e) without affecting the magnitude of total HVA currents (Fig. 2a,e) , indicating that Sema3A suppressed L-type currents. We further isolated the Sema3A-induced growth-cone Ca 2+ currents using Ni 2+ (R (Ca V 2.3)-and T-type channel blocker) and nimodipine and found that N-type currents were significantly decreased (Fig. 2c,e) . In contrast, Sema3A caused a four-to fivefold increase in R (Ca V 2.3)-type currents isolated in the presence of nimodipine and ω-conotoxin GVIA (Fig. 2d,e) that was abolished by bath-applied SNX-482 (Fig. 2d,e) Table S1 ), it probably caused an increase in the number of Ca V 2.3 in the growth-cone plasma membrane rather than modulating their gating properties ( Supplementary Fig. S5e ).
Expression of Ca V 2.3 in vivo requires Sema3A
To examine the role of Sema3A in Ca V 2.3 function in vivo, we first tested the effect of downregulating endogenous Sema3A by injecting an antisense morpholino oligonucleotide (A-MO) against Xenopus Sema3A (xSema3A) messenger RNA (xSema3A A-MO; a sense MO (xSema3A S-MO) served as a control) into one dorsal blastomere of four-cell stage embryos along with GFP mRNA as an injection marker. We then immunostained whole mounts 30 and imaged the immunoand GFP fluorescence (Fig. 3a) to compare the MO-injected side of the spinal cord with the uninjected side in the same embryo (Fig. 3a) and also with uninjected control embryos. Immunostaining with a polyclonal antibody against human Sema3A (hSema3A) revealed a high level of bilateral expression of xSema3A in stage 30-32 spinal cords (Fig. 3b ) that was reduced significantly by xSema3A A-MO (Fig. 3c , (Fig. 3g ) similar to that of xSema3A (Fig. 3b) . The specificity of the anti-Ca V 2.3 α 1E antibodies was confirmed by their detection of overexpressed mouse Ca V 2.3 α 1E (mCa V 2.3 α 1E ) when endogenous xCa V 2.3 α 1E was downregulated by a specific A-MO (xCa V 2.3 α 1E A-MO; Supplementary Fig. S6 ). The endogenous (Fig. 3i,k) . The effect of xSema3A A-MO was specific, because overexpression of hSema3A reversed the reduction of xCa V 2.3 α 1E (Fig. 3j,k ). These results demonstrate that Sema3A is required for the expression of Ca V 2.3 in the Xenopus spinal cord in vivo.
Dendrite identity in vivo requires Sema3A-Ca V 2.3 signalling
We next confirmed that Sema3A signalling is required to specify the dendrite identity in vivo by analysing MAP2 immunoreactivity in whole-mount spinal cords. Dendrites of developing spinal neurons first became prominently MAP2 positive (Fig. 4a,b) at the stage 42 tadpole (Fig. 4a, left) . MAP2 immunoreactivity showed relatively simple dendritic arbors projecting ventrally (Fig. 4b,c) . Their morphology and the location of their soma suggest that these neurons are highly likely to be either CINs or ascending interneurons 31 . We found that MAP2 immunoreactivity in the Sema3A A-MO-injected (Fig. 4d,g and Supplementary Movie S3), but not the xSema3A S-MO-injected (Fig. 4e,g ), side of spinal cords was significantly reduced compared with the uninjected side of the same spinal cords, and this effect was reversed by overexpression of hSema3A (Fig. 4f,g ). Injection of A-MO against xNpn-1 ( Fig. 4g) but not the control xNpn-1 S-MO (Fig. 4g ) also significantly reduced the MAP2 immunoreactivity in the injected side of the spinal cord. Thus, Sema3A is required to specify the dendrite identity.
Because the reduction of MAP2 immunoreactivity caused by downregulation of either xSema3A or xNpn-1 could have caused defects in cell migration 32 , we examined the effects of downregulation of xCa V 2.3 α 1E on the dendrite identity. Consistent with the idea that Ca V 2.3 is a Sema3A downstream effector required to specify the dendrite identity, MAP2 immunoreactivity was significantly reduced by xCa V 2.3 α 1E A-MO, to an extent similar to that caused by xSema3A A-MO (Fig. 5a ,f and Supplementary Movie S4), but not by xCa V 2.3 α 1E S-MO (Fig. 5b,f) . Injection of the mRNA for mCa V 2.3 α 1E together with xCa V 2.3 α 1E A-MO reversed the reduction of MAP2 immunoreactivity (Fig. 5c,f) However, restoration of MAP2 immunoreactivity by mCa V 2.3 α 1E in the side of the spinal cord treated with xCa V 2.3 α 1E A-MO occurred only in the presence of endogenous xSema3A (Fig. 5c,f) , not when xSema3A was downregulated (Fig. 5e,f) , suggesting that other parallel signal(s) are also required to specify the dendrite identity. We also tested the effects of pharmacological blockade of Ca V 2.3 on the acquisition of the dendrite identity by administering different doses of SNX-482 into the spinal cords of stage 30-32 tailbuds (Fig. 5g) . Administration of 45 µM SNX-482 eliminated almost all dendrites (Fig. 5k,l) while lower doses caused significant reductions (Fig. 5i,j,l) . The local administration of nimodipine (Fig. 5h,l) or ω-conotoxin GVIA (Fig. 5l) had no significant effect. These results support the idea that the Sema3A signal propagates through Ca V 2.3, whose activity is required for the acquisition of the dendrite identity.
Ca V 2.3 suppresses the axon identity in vivo
Since Sema3A induced the conversion of axons of cultured xSCINs to dendrites in vitro (Fig. 1) , we tested whether downregulation of Ca V 2.3 expression also affects the axon identity in vivo. Whole mounts of normal stage 42 tadpole spinal cords showed equal intensities of bilateral axon tracts along their longitudinal axes (Fig. 6a,b) . Injection of xCa V 2.3 α 1E A-MO (Fig. 6c,g ), but not the control xCa V 2.3 α 1E S-MO (Fig. 6d,g ), resulted in a significant increase of tau-1 immunoreactivity in the injected side of the spinal cords (Fig. 6c,d , lower panels), as compared with control, uninjected animals (Fig. 6b,g ).
The increased tau-1 immunoreactivity was particularly noticeable close to the ventral midline (Fig. 6c) , where it is normally absent (Fig. 6b) , implying that the default neuronal polarization state in the absence of Ca V 2.3 is that of axons. Furthermore, local administration of SNX-482 into the spinal cord caused a significant increase in tau-1 immunoreactivity throughout the spinal cord (Fig. 6e,g ). In contrast, administration of neither nimodipine (Fig. 6f,g ) nor ω-conotoxin GVIA (Fig. 6g) had a significant effect. Western blot analysis showed that the ratio of MAP2 to tau-1 in total protein extracted from the SNX-482-treated spinal cords was significantly lower than that from untreated, control, spinal cords ( Supplementary Fig. S7 ), corroborating the immunohistochemical observations of spinal cords shown above. Thus, Ca V 2.3 activity is required not only for acquisition of the dendrite identity but also for suppression of the axon identity.
To exclude off-target effects of A-MO treatment, we examined the neuronal integrity of xCa V 2.3 α 1E A-MO-treated animals. We microinjected Texas Red conjugated with dextran of relative molecular mass 70,000 (M r 70K) into one dorsal blastomere of 64-cell stage embryos into which xCa V 2.3 α 1E A-MO had previously been injected at the four-cell stage (Fig. 6h) . We then visualized individual spinal neurons in the MO-injected side of stage 42 tadpole spinal cords using Texas Red. We imaged isolated, putative xSCINs whose soma were located about two-thirds of the distance from the ventral midline and whose single axon and dendrites projected ventrally (Fig. 6i,k,  control) . Individual putative xSCINs in the side of spinal cords 
(9)
(10) (8) * treated with xCa V 2.3 A-MO, indeed, showed multiple axon-like neurites that emanated from the proximal segment and many that projected longitudinally in the ipsilateral axon tract (Fig. 6j,l) , but such axon-like neurites were only rarely observed in control animals (Fig. 6i,k) . The ipsilateral projection (Fig. 6j,l) of these putative xSCIN axons may be a result of their reduced sensitivity to netrin-1 (ref. 33) . These results clearly demonstrate that the activity of Ca V 2.3 suppresses the axon identity.
cGMP signalling induces Ca V 2.3 expression and dendrite identity
We previously showed that Sema3A triggers the local production of cGMP by sGC (ref. 16) . A recent study showed that cGMP-protein kinase G (PKG) signalling induces initiation of the dendrite identity in undifferentiated neurites of cultured hippocampal neurons 34 . Interestingly, bath application of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), an inhibitor of sGC, prevented the induction of Ca V 2.3 currents by a gradient of Sema3A in xSCIN growth cones (Fig. 7a) . Moreover, inhibition of sGC by local administration of ODQ abolished not only Ca V 2.3 α 1E expression (Fig. 7b,h ), but also dendrite formation (Fig. 7e,h ), suggesting that cGMP signalling functions as an upstream regulator of the expression of Ca V 2.3 as well as acquisition of the dendrite identity. Surprisingly, a gradient of Rp-8-pCPT-cGMPS, a PKG-inhibiting cGMP analogue 16 , induced R (Ca V 2.3)-type currents (Fig. 7a) and pre-empted their induction by Sema3A (Fig. 7a) . Moreover, Rp-8-pCPT-cGMPS-induced R (Ca V 2.3)-type currents were not 
Figure 7
Sema3A-induced cGMP causes recruitment and expression of Ca V 2.3 and PKG is required as a co-activator for acquisition of the dendrite identity. (a) Representative traces of Ca 2+ currents (left), summary of the current I-V relationship (centre) of R (Ca V 2.3)-type currents and cumulative distribution of peak R (Ca V 2.3)-type currents (right) monitored in cultured xSCIN growth cones. Either ODQ (1 µM), Rp-8-pCPT-cGMPS (2.5 µM) or CHX (25 µM) was applied in the bath 30 min before experiments were performed. Sema3A (2,000 U ml −1 in micropipettes) was applied to the growth cone as a gradient. (b-g, upper panels, i-n, upper panels) lmmunofluorescence images of Xenopus spinal cords immunostained for xCa V 2.3 α 1E (b-d, upper panels,i-k, upper panels) or MAP2 (e-g, upper panels, l-n, upper panels), without MO injection (b-g, upper panels) or with injection of A-MO specific for either xSema3A (i-k, upper panels) or xCa V 2.3 α 1E (l-n, upper panels). (b-g, lower panels, i-n, lower panels) Signals in red (b-d, lower panels, i-k, lower panels) and traces in black (e-g, lower panels, l-n, lower panels) indicate the location of the xCa V 2 .3 α 1E and MAP2 immunoreactivities, respectively, which are overlaid with signals from the GFP injection marker (green, i-k, lower panels, l-n, lower panels). ODQ (1 mM), Rp-8-pCPT-cGMPS (0.25 mM) or 8-Br-cGMP (1 mM) were injected into the hindbrain and spinal cord of stage 30-32 tailbud animals (see Fig. 5g affected by ODQ, concordant with the notion that cGMP is required to target functional Ca V 2.3 to the plasma membrane. Importantly, these R (Ca V 2.3)-type currents were eliminated by pretreatment with cycloheximide (CHX), a protein synthesis inhibitor (Fig. 7a) , suggesting that cGMP, not PKG, mediates both the Sema3A-induced synthesis of Ca V 2.3 proteins and their targeting to the plasma membrane in vitro. Rp-8-pCPT-cGMPS also caused a significant increase in the expression of xCa V 2.3 α 1E (Fig. 7c,h) , which extended beyond the marginal zones of the spinal cord. It is noteworthy that pretreatment with CHX eliminated the Sema3A-induced expression of Ca V 2.3 both in vitro and in vivo (Supplementary Fig. S8 ), supporting the idea that cGMP regulates the expression of functional Ca V 2.3 at the translational level. In contrast, Rp-8-pCPT-cGMPS drastically reduced MAP2 immunoreactivity (Fig. 7f,h ) to an extent similar to that caused by treatment with either ODQ (Fig. 7e,h ) or SNX-482 (Fig. 5i-l) , demonstrating that PKG activity is required for the acquisition of the dendrite identity. Consistent with these observations, local administration of 8-Br-cGMP, a PKG-activating cGMP analogue, enhanced both the expression of xCa V 2.3 α 1E (Fig. 7d,h ) and dendrite formation (Fig. 7g,h) .
Finally, we downregulated the expression of either xSema3A or xCa V 2.3 α 1E with specific A-MOs in one side of spinal cords and tested the effects of varying the levels of cGMP on the expression of xCa V 2.3 α 1E or acquisition of the dendrite identity. Despite the absence of Sema3A, local administration of either Rp-8-pCPT-cGMPS (Fig. 7j,o) or 8-Br-cGMP (Fig. 7k,o) induced the expression of xCa V 2.3 α 1E , while local administration of ODQ caused their significant reduction (Fig. 7i,o) , supporting the idea that cGMP induces the expression of xCa V 2.3 α 1E . In contrast, ODQ (Fig. 7l,o) or Rp-8-pCPTcGMPS (Fig. 7m,o) prevented the appearance of dendrites even in the presence of the xCa V 2.3. However, local administration of 8-Br-cGMP failed to rescue dendrites in the absence of xCa V 2.3 (Fig. 7n,o) , indicating that Ca V 2.3 is required for the acquisition of the dendrite identity. Taken together, our results reveal that Sema3A-induced cGMP-PKG signalling regulates the cGMP-dependent expression of functional xCa V 2.3 that, together with PKG as a co-effector, specifies the dendrite identity while suppressing axon identity.
DISCUSSION
Extracellular factors signal to regulate the initiation and maintenance of the axon identity 4, 5, 35 and dendrite growth and branching [13] [14] [15] . However, the signalling events that regulate the acquisition of the dentride identity in response to extracellular factors are unknown. We demonstrate in vitro and in vivo that a secreted guidance factor, Sema3A, induces the dendrite identity and concomitantly suppresses the axon identity by inducing the expression of functional Ca V 2.3. We further demonstrate that Sema3A-triggered cGMP production and PKG activity are required, respectively, for the expression of Ca V 2.3 and acquisition of the dendrite identity.
We found that the relatively high Sema3A concentration required to convert the axons of cultured xSCINs to dendrites caused growth-cone depolarization and the recruitment of functional Ca V 2.3 to the plasma membrane. We also found that increased expression of Sema3A occurs in close spatiotemporal proximity to the expression of Ca V 2.3 in the spinal cords of tailbud-stage animals, when putative dendrites emanate from pre-existing axons. We propose that high Sema3A concentration is required to induce Ca V 2.3-mediated Ca 2+ signalling in growth cones, which, in turn, causes the upregulation of MAP2 required to specify the dendrite identity while simultaneously downregulating the unphosphorylated tau required to specify the axon identity (see Fig. 8 ). Local protein synthesis and trafficking can occur in cultured growth cones of Xenopus retinal ganglion cells (xRGCs) within 5 min of their exposure to Sema3A (ref. 36) . Thus, Sema3A signalling may induce cGMP-dependent de novo synthesis of Ca V 2.3 and its targeting to the plasma membrane. Sema3A has been demonstrated to activate the ERK (extracellular-signal-regulated kinase)-TOR (target of rapamycin) signalling pathway during repulsion/collapse of cultured xRGC growth cones 37, 38 . CNrasGEF, a cyclic nucleotide-activated guanine exchanging factor that activates Ras family GTPase proteins, could couple Sema3A-induced production of cGMP to the ERK-TOR signalling pathway 39 to induce de novo synthesis of Ca V 2.3. A similar mechanism could account for the cGMP-mediated targeting of Ca V 2.3 to the plasma membrane, since Ras/Rap1 are known to induce vesicle transport that traffics the ionotropic glutamate receptor 40 , and Sema3A enhances axonal vesicle transport 21 . The identity of neurites as either axons or dendrites depends on the relative signalling of cyclic AMP-protein kinase A (PKA) and cGMP-PKG; greater cGMP-PKG signalling causes undifferentiated neurites of hippocampal neurons to become dendrites 34 . PKG antagonizes acquisition of the axon identity induced by PKA-dependent phosphorylation of LKB1 (refs 35,41) 16 and simultaneously opposing the PKA activity required for the axon identity. The details of the mechanism that underlies the activation of Ca V 2.3 required for the acquisition of the dendrite identity is unknown, but may require an unidentified factor(s) (Factor 'X', Fig. 8 ). This hypothesized factor is unlikely to be any of the known signalling molecules that promote the axon identity because disruption of the expression of these molecules does not cause the conversion of axons to dendrites. Sema3A causes the phosphorylation of collapsing-responsemediator protein-2 (CRMP2) through the action of cyclin-dependent kinase-5 (Cdk-5) and GSK3β (ref. 43) , which is known to suppress the axon identity 44 47 has been demonstrated, their function in vivo has not been elucidated previously. Our study demonstrates the importance of the spatiotemporal and dynamic expression patterns of both guidance factors and ion channels in establishing the neurite identity during nervous system development. Ca V 2.3-induced acquisition of the dendrite identity and the simultaneous suppression of the axon identity may also contribute to the Sema3A-induced failure of axons to regenerate after nerve injury 48 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology and GFP were synthesized with mMESSAGE mMACHINE (Ambion) and purified on NucAwayTM Spin Columns (Ambion) as described by the manufacturer. mRNAs were injected into one dorsal blastomere of four-cell stage Xenopus embryos 16, 17, 29 . Each blastomere was injected with 4-8 nl of 0.5 µg µl −1 mRNA for NP1-0111, 0.5 µg µl −1 mRNA for hSema3A or 0.5 µg µl −1 mRNA for mCa V 2.3 α 1E , and 0.25 µg µl −1 mRNA for GFP as an expression indicator. Primary Xenopus spinal neurons derived from developmental stage 26 embryos were cultured at 23-25 • C for 16-20 h and used for growth-cone electrophysiology ( Fig. 2 and Supplementary Fig. S5a-c) and immunocytochemistry (Supplementary Fig. S3a,b) . To examine the neurite identity and expression of functional AMPA receptor channels ( Supplementary Fig. S4 ), cells were plated on coverslips that had been coated for 4-6 h each with poly-l-lysine (100 µg ml −1 ) and laminin (80 µg ml −1 ) and incubated for 3-4 h at 23-25 • C before use.
Morpholino oligonucleotides. Antisense morpholino oligonucleotides (A-MO)
were designed to target a 25-nucleotide sequence beginning at the start codon of the mRNA for xSema3A (5 -ATG CAA TCC AGG TCA GAG AGC CCA T -3 ) or xCa V 2.3 α 1E (recombinant clone xCacna1e, 5 -CTA TGT GAT ATG ATT ATT TAT GAC C-3 ) as recommended by GeneTools. Corresponding sense-sequence oligonucleotides (S-MOs) of the same regions of the xSema3A mRNA (5 -ATG-GGC-TCT-CTG-ACC-TGG-ATT-GCA-T-3 ) or the xCacna1e mRNA (5 -GGT CAT AAA TAA TCA TAT CAC ATA G-3 ) were used as controls. MOs (1 mM, total 2 nl) and/or mRNA for mCacna1e (0.5 µg µl −1 ) were injected together with mRNA for GFP (0.25 µg µl −1 ) into one dorsal blastomere of four-cell stage embryos.
Guidance proteins and pharmacological drugs. Sema3A (2 U ml −1 ) and netrin-1 (5 ng ml −1 ) were prepared as described 16, 17, 21, 27, 29, 49 . To test the conversion of the identities of individual neurites and for growth-cone electrophysiology, 2,000 U ml −1 Sema3A (in micropipettes) was applied as a gradient. The biological activity of Sema3A (U ml −1 ) was evaluated using a collapse assay of chick dorsal root ganglion neurons 21 . All pharmacological agents were bath-applied 30 min before experiments were carried out unless otherwise indicated. Agonist and antagonists were purchased from Calbiochem, Peptide Institute, Sigma, and Tocris. Fig. S3c ). Animals were fixed with PLP (4% paraformaldehyde, 0.075 M lysine, 0.01 M sodium metaperiodate) solution, soaked in 30% sucrose and embedded in optimal cutting temperature (OCT) compound (Fisher Scientific). Frozen sections were cut from embryos over a 400 µm region of the spinal cord beginning about 400 µm posterior to the back of the eyes.
Electrophysiology. To measure AMPA-induced holding-current shifts, an internal recording solution was used that contained the following (in mM): 140 CsMeSO 4 , 1 NaCl, 1 MgSO 4 , 1 Mg-ATP, 1 QX-314, 0.25 BAPTA and 10 HEPES (pH 7.4), and bathing solution was used that contained (in mM) 83.4 NaCl, 8.6 Na-gluconate, 2.6 KCl, 35 TEA-Cl, 2 CaCl 2 and 10 HEPES at pH 7.4). Wholecell recordings at the growth cone of cultured CINs were made as described previously 16, 17, 29 . Whole-cell recordings were collected under a voltage-clamp configuration at −70 mV. Holding-current shifts in response to AMPA gradients (25 mM in micropipettes) were monitored in the presence or absence of 6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-sulphonamide (NBQX) applied as a gradient (5 mM in micropipettes). Recording and bathing solutions used to measure membrane potentials 16 and to isolate Ca 2+ currents 17, 29 were as described previously. Sema3A was applied as a gradient for at least 5 min before whole-cell recordings were made. Whole-cell membrane potentials were measured under a current-clamp configuration without accessing currents. Whole-cell Ca 2+ currents evoked by depolarization from a holding potential of −50 mV to +50 mV in 10-mV incremental steps of 100 ms each were recorded with a patch-clamp amplifier (Axopatch 200B, Axon Institute). Ca 2+ -channel activity was evaluated by measuring peak inward currents. Leak currents evoked by an inverse voltage-ramp from +120 to −120 mV were measured in the presence or absence of gradients of Sema3A and were subtracted from the total Ca 2+ currents. Data were filtered at 2 kHz and collected at 250 Hz (membrane potentials) and 10 kHz (AMPA-induced holding-potential shifts and Ca 2+ currents).
Microinjection. For the visualization of individual neurons, Alexa Fluor 488
dextran, M r 10K (0.1 µg µl −1 ), alone or together with MOs, was injected into one dorsal blastomere of embryos at the four-cell stage followed by injection of Texas Red dextran, M r 70K (1 mM), at the same injection site (as indicated by the membrane penetration mark of the previous injection) of embryos at the 64-cell stage. For the local administration of antagonists and agonist, the Ca 2+ -channel blockers (SNX-482 (25-45 µM), nimodipine (500 µM) and ω-conotoxin GVIA (90 µM)), ODQ (100 µM), Rp-8-pCPT-cGMPS (2.5 mM) and 8-Br-cGMP (10 mM) were injected along with fluorescein isothiocyanate dextran, M r 70K (1 mM) into the hindbrain and at multiple sites along the spinal cord of tailbud stage 30-32 animals (total about 30 nl each, see Fig. 5g ).
Whole-mount immunohistochemistry. Xenopus tailbud and tadpole stage animals (control, A-MOs or S-MOs injected or overexpressing either hSema3A or mCa V 2.3 α 1E ) were fixed in a solution containing 4% paraformaldehyde (vol/vol) and 4% sucrose (wt/vol) for 24 h at 4 • C. The blocking solution contained 0.5% fish gelatin (wt/vol) and 0.2% Triton X-100 (vol/vol). Primary antibodies were applied at a 1:100 dilution for 24 h at 4 • C: anti-Sema3A (AF1250, R&D Systems), anti-Npn-1 (C-19, Santa Cruz Biotechnology), tau-1, anti-MAP2, and anti-m Ca V 2.3 α 1E (H-60, sc-28618, Santa Cruz Biotechnology). Secondary antibodies were applied at a 1:100 dilution for 2 h at 24 • C: Cy3-conjugated antibodies against mouse IgG (Jackson ImmunoResearch) for tau-1 and anti-MAP2, Cy3-conjugated antibodies against goat IgG (Jackson ImmunoResearch) for anti-Sema3A and Cy3-conjugated antibodies against rabbit IgG (Jackson ImmunoResearch) for anti-mCa V 2.3 α 1E .
In vivo imaging. Images of 1-or 2-µm-thick z-series optical slices (150-180 or 75-90 slices, respectively) taken with an ORCA-ER CCD camera (Hamamatsu) attached to a BX51WI microscope (XLUMPlanF1, 20×,0.95 NA, Olympus) were recorded using open-source µ Manager software (http://www.micro-manager.org/). Deconvolution was carried out with ImageJ software using the Iterative Deconvolve 3D plugin (DAMAS3 algorithm with the Wiener filter, Optinav), and the images of each slice were used to measure the volume and mean area pixel intensities with Amira (Visage Imaging), Imaris (Bitplane) or ImageJ. Flattened images of the fluorescent signals from slices that revealed the maximum intensity projections are shown in Figs 3b-e,g-j, 4c-f, 5a-e,h-k, 6b-f, 7b-g,i-n and Supplementary Figs S6c and S8d. The average intensity projections were applied to visualize individual neurons shown in Fig. 6i -l. The intensities of MAP2 and tau-1 immunoreactivity decrease along the spinal cord in the rostral-to-caudal direction, coincident with the progressive developmental delay that occurs in this direction. To quantitate the immunoreactivity signals,infrared intensity along 300 µm of the longitudinal length of the spinal cord was measured at the position where it was about 100 µm in diameter.
Western blotting. Spinal cords were isolated from stage 42, non-treated control
Xenopus tadpoles or tadpoles injected locally with either SNX-482, ω-conotoxin GVIA or nimodipine. Specimens were lysed with Tris-Triton lysis buffer (in millimolar: 100 Tris at pH 7.4, 100 NaCl, 1 EDTA, 1 EGTA, 1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate and protease inhibitor cocktail; AMRESCO). Proteins in these lysates were separated by 7.5% SDS-polacrylamide gel electrophoresis and electro-transferred onto polyvinylidene difluoride membranes (Millipore) as previously described 50 . The membranes were divided into two sections between the M r 130K and 250K markers (FERMENTAS). The sections containing the higher-and lower-molecular-weight proteins were stained, respectively, with anti-MAP2 (1:200) or tau-1 (1:400) antibodies. The signals were detected using a horseradish peroxidase-based ABC kit (Vector Laboratories). ImageJ was used to measure the densitometry of bands and the ratio of tau-1 immunoreactivity to MAP2 immunoreactivity of individual samples was analysed.
Statistical analysis. All the experimental data were obtained from at least three different batches of Xenopus oocytes, six different individual animals and 13 different cultured neurons. The Mann-Whitney U -test was used to calculate significant differences from the corresponding controls except that the Wilcoxon-signed rank test was used for Supplementary Fig. S1c . 
